Biosimilars

The FDA issued final guidelines Friday concerning the interchangeability of biosimilars with biologics with an intention to make the former easily available to patients, just as how generics are used for branded drugs. What Happened The FDA's latest guidelines outlined the studies a...

In a speech on Wednesday, U.S. Food and Drug Administration commissioner Scott Gottlieb ripped drug makers for blocking competitors from bringing potentially cheaper biosimilar drugs to the market. On Thursday, Citron Research, which is known for its short theses, tweeted that Gottlieb’s...

The health care sector, the third-largest sector weight in the S&P 500, is surging. Generic drugmakers have been a source of strength for the group. For example, the VanEck Vectors Generic Drugs ETF (NASDAQ: GNRX) is up 9 percent since the start of 2018 and resides near all-time highs after...

From the looks of it, pharmacy is the place to be. The global sector has hundreds of players, private and public, and household brands like Pfizer Inc. (NYSE: PFE), Merck & Co., Inc. (NYSE: MRK) and Eli Lilly and Co (NYSE: LLY) have long dominated the crowded field. Even so, and despite the...